发布求助
文献互助 智能选刊 最新文献

Annals of Oncology最新文献

筛选
英文 中文
54P BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic biliary tract carcinoma (BTC)
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.063
{"title":"54P BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic biliary tract carcinoma (BTC)","authors":"","doi":"10.1016/j.annonc.2024.08.063","DOIUrl":"10.1016/j.annonc.2024.08.063","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015825/pdfft?md5=2fb2bfa72f4b03d788c93fb8efa4e157&pid=1-s2.0-S0923753424015825-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
42P Correlation of circulating tumor cells with cancer stage
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.051
{"title":"42P Correlation of circulating tumor cells with cancer stage","authors":"","doi":"10.1016/j.annonc.2024.08.051","DOIUrl":"10.1016/j.annonc.2024.08.051","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015709/pdfft?md5=22365fdb77709db86078a2dac9cfbb53&pid=1-s2.0-S0923753424015709-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18P The role of CTNNA1 truncating variants in hereditary diffuse gastric cancer (HDGC)
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.027
{"title":"18P The role of CTNNA1 truncating variants in hereditary diffuse gastric cancer (HDGC)","authors":"","doi":"10.1016/j.annonc.2024.08.027","DOIUrl":"10.1016/j.annonc.2024.08.027","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015461/pdfft?md5=ee330dd8b2b31989e88b33a9e2c0b6f2&pid=1-s2.0-S0923753424015461-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
21P DNAJC1 inhibit the ferroptosis of glioma cells through stabilizing GPX4 by competing with TRIM21
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.030
{"title":"21P DNAJC1 inhibit the ferroptosis of glioma cells through stabilizing GPX4 by competing with TRIM21","authors":"","doi":"10.1016/j.annonc.2024.08.030","DOIUrl":"10.1016/j.annonc.2024.08.030","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015497/pdfft?md5=e8f56a059bfb19ac8fa951d959bfe6b9&pid=1-s2.0-S0923753424015497-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
76P Improving access to whole genome sequencing for patients with cancer of unknown primary using formalin-fixed paraffin embedded tissues and cell-free DNA
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.084
{"title":"76P Improving access to whole genome sequencing for patients with cancer of unknown primary using formalin-fixed paraffin embedded tissues and cell-free DNA","authors":"","doi":"10.1016/j.annonc.2024.08.084","DOIUrl":"10.1016/j.annonc.2024.08.084","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092375342401603X/pdfft?md5=9edc1c07bd97ca3e937f00940fce695c&pid=1-s2.0-S092375342401603X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
77P Whole-exome mutation profiling of cfDNA from over 2000 samples in major cancer indications
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.085
{"title":"77P Whole-exome mutation profiling of cfDNA from over 2000 samples in major cancer indications","authors":"","doi":"10.1016/j.annonc.2024.08.085","DOIUrl":"10.1016/j.annonc.2024.08.085","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016041/pdfft?md5=a5ad1e29a1159269e63086c5edc40c83&pid=1-s2.0-S0923753424016041-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
12P STING-activable pyroptotic nanoparticles deliver GSDMDNT mRNA for in situ pancreatic cancer vaccination and immunotherapy
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.022
{"title":"12P STING-activable pyroptotic nanoparticles deliver GSDMDNT mRNA for in situ pancreatic cancer vaccination and immunotherapy","authors":"","doi":"10.1016/j.annonc.2024.08.022","DOIUrl":"10.1016/j.annonc.2024.08.022","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015412/pdfft?md5=b8f39fd1bc4a201add51080d347ab4b1&pid=1-s2.0-S0923753424015412-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
92P Transformative diagnostics in urothelial carcinoma: Utilizing targeted NGS and LP-WGS for non-invasive detection and personalized medicine
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.100
{"title":"92P Transformative diagnostics in urothelial carcinoma: Utilizing targeted NGS and LP-WGS for non-invasive detection and personalized medicine","authors":"","doi":"10.1016/j.annonc.2024.08.100","DOIUrl":"10.1016/j.annonc.2024.08.100","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424016193/pdfft?md5=037f7f3be6a34894f9ac80909b3d4db4&pid=1-s2.0-S0923753424016193-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Notice and Disclaimer
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/S0923-7534(24)03808-0
{"title":"Notice and Disclaimer","authors":"","doi":"10.1016/S0923-7534(24)03808-0","DOIUrl":"10.1016/S0923-7534(24)03808-0","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424038080/pdfft?md5=6520f2c9e1a512a4f3ec50cdfea628d3&pid=1-s2.0-S0923753424038080-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
53P Envafolimab and chidamide in combination with GEMOX as first-line treatment for advanced and metastatic biliary tract cancer (B-Enefits/SCOG-B001): A single-arm, exploratory, phase II trial: Interim report
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.062
{"title":"53P Envafolimab and chidamide in combination with GEMOX as first-line treatment for advanced and metastatic biliary tract cancer (B-Enefits/SCOG-B001): A single-arm, exploratory, phase II trial: Interim report","authors":"","doi":"10.1016/j.annonc.2024.08.062","DOIUrl":"10.1016/j.annonc.2024.08.062","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015813/pdfft?md5=d005319062f91922f79990456ca4b9a7&pid=1-s2.0-S0923753424015813-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信